706 related articles for article (PubMed ID: 25904241)
1. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.
Schrottmaier WC; Kral JB; Badrnya S; Assinger A
Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241
[TBL] [Abstract][Full Text] [Related]
2. Effect of P2Y12 inhibitors on inflammation and immunity.
Thomas MR; Storey RF
Thromb Haemost; 2015 Aug; 114(3):490-7. PubMed ID: 26156883
[TBL] [Abstract][Full Text] [Related]
3. Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model.
Thomas MR; Outteridge SN; Ajjan RA; Phoenix F; Sangha GK; Faulkner RE; Ecob R; Judge HM; Khan H; West LE; Dockrell DH; Sabroe I; Storey RF
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2562-70. PubMed ID: 26515417
[TBL] [Abstract][Full Text] [Related]
4. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
[TBL] [Abstract][Full Text] [Related]
5. Use of antiplatelet agents in sepsis: a glimpse into the future.
Akinosoglou K; Alexopoulos D
Thromb Res; 2014 Feb; 133(2):131-8. PubMed ID: 24103487
[TBL] [Abstract][Full Text] [Related]
6. A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patients.
Straub N; Beivers A; Lenk E; Aradi D; Sibbing D
Thromb Haemost; 2014 Feb; 111(2):290-9. PubMed ID: 24154566
[TBL] [Abstract][Full Text] [Related]
7. Response variability to P2Y12 receptor inhibitors: expectations and reality.
Siller-Matula JM; Trenk D; Schrör K; Gawaz M; Kristensen SD; Storey RF; Huber K;
JACC Cardiovasc Interv; 2013 Nov; 6(11):1111-28. PubMed ID: 24262612
[TBL] [Abstract][Full Text] [Related]
8. Novel platelet ADP P2Y12 inhibitors in the treatment of acute coronary syndrome.
Tan GM; Lam YY; Yan BP
Cardiovasc Ther; 2012 Aug; 30(4):e167-73. PubMed ID: 21883998
[TBL] [Abstract][Full Text] [Related]
9. P2Y
Mansour A; Bachelot-Loza C; Nesseler N; Gaussem P; Gouin-Thibault I
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092903
[TBL] [Abstract][Full Text] [Related]
10. The role of perioperative antiplatelet therapy and platelet reactivity testing in carotid revascularization: overview of the evidence.
Leunissen TC; De Borst GJ; Janssen PW; ten Berg JM
J Cardiovasc Surg (Torino); 2015 Apr; 56(2):165-75. PubMed ID: 25600432
[TBL] [Abstract][Full Text] [Related]
11. The role of platelets in inflammation.
Thomas MR; Storey RF
Thromb Haemost; 2015 Aug; 114(3):449-58. PubMed ID: 26293514
[TBL] [Abstract][Full Text] [Related]
12. The role of P2Y₁₂ receptor and activated platelets during inflammation.
Liverani E; Kilpatrick LE; Tsygankov AY; Kunapuli SP
Curr Drug Targets; 2014; 15(7):720-8. PubMed ID: 24845219
[TBL] [Abstract][Full Text] [Related]
13. Platelets in atherosclerosis.
Lievens D; von Hundelshausen P
Thromb Haemost; 2011 Nov; 106(5):827-38. PubMed ID: 22012554
[TBL] [Abstract][Full Text] [Related]
14. Role of Platelet Transfusion in the Reversal of Anti-Platelet Therapy.
Nagalla S; Sarode R
Transfus Med Rev; 2019 Apr; 33(2):92-97. PubMed ID: 30814031
[TBL] [Abstract][Full Text] [Related]
15. Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors.
Adamski P; Koziński M; Ostrowska M; Fabiszak T; Navarese EP; Paciorek P; Grześk G; Kubica J
Thromb Haemost; 2014 Aug; 112(2):224-42. PubMed ID: 24763899
[TBL] [Abstract][Full Text] [Related]
16. P2Y12 Receptor Modulates Sepsis-Induced Inflammation.
Liverani E; Rico MC; Tsygankov AY; Kilpatrick LE; Kunapuli SP
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):961-71. PubMed ID: 27055904
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing.
Freynhofer MK; Gruber SC; Grove EL; Weiss TW; Wojta J; Huber K
Thromb Haemost; 2015 Aug; 114(3):459-68. PubMed ID: 26272640
[TBL] [Abstract][Full Text] [Related]
18. How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors--is an algorithm the answer?
Siller-Matula JM; Trenk D; Schrör K; Gawaz M; Kristensen SD; Storey RF; Huber K;
Thromb Haemost; 2015 Jan; 113(1):37-52. PubMed ID: 25231675
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patients.
Rollini F; Franchi F; Tello-Montoliu A; Patel R; Darlington A; Ferreiro JL; Cho JR; Muñiz-Lozano A; Desai B; Zenni MM; Guzman LA; Bass TA; Angiolillo DJ
JACC Cardiovasc Interv; 2014 Apr; 7(4):426-34. PubMed ID: 24630878
[TBL] [Abstract][Full Text] [Related]
20. The Function and Regulation of Platelet P2Y12 Receptor.
Li X; Zhang G; Cao X
Cardiovasc Drugs Ther; 2023 Feb; 37(1):199-216. PubMed ID: 34319489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
